Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization. More information can be found at www.savarapharma.com. More information on the Phase 3 IMPALA-2 clinical trial in aPAP can be found at www.impala2.com
Location: United States, Colorado
Employees: 11-50
Total raised: $88.4M
Founded date: 2007
Investors 6
| Date | Name | Website |
| - | Puget Soun... | pugetsound... |
| - | Hercules C... | htgc.com |
| - | 37 Venture... | 37ventures... |
| - | Keiretsu F... | keiretsufo... |
| - | Haas Portm... | haasportma... |
| - | Bain Capit... | baincapita... |
Funding Rounds 7
| Date | Series | Amount | Investors |
| 21.04.2022 | - | $26.5M | - |
| 01.03.2016 | Series C | $20M | - |
| 21.03.2013 | Series B | $7.4M | - |
| 18.07.2012 | - | $3M | Keiretsu F... |
| 12.06.2012 | Series B | $8.6M | - |
| - | Series B | $16M | - |
| - | Series B | $6.9M | - |
Mentions in press and media 25
| Date | Title | Description | Source |
| 13.07.2023 | Savara Announces Pricing of $80 Million Underwritten Offerin... | - | tcgcrossov... |
| 01.07.2021 | Savara : Announces First Patient Dosed in Pivotal Phase 3 Au... | AUSTIN, Texas - Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on ra... | marketscre... |
| 15.03.2021 | Savara Announces Closing of $130 Million Public Offering Fol... | AUSTIN, Texas--(BUSINESS WIRE)--Mar 15, 2021-- Savara Inc. (Nasdaq: SVRA), an orphan lung disease c... | oaoa.com/n... |
| 09.01.2017 | Savara jumping to the NYSE in reverse merger with zombie... | After raising $20 million and laying out plans for a Phase III pivotal trial of a reformula... | endpts.com... |
| 01.09.2016 | Ten Life Science Startups to Watch in Austin | Austin is home to a small, but growing biotech and medical technology industry with about 200 comp... | siliconhil... |
| 23.06.2016 | Savara Pharmaceuticals Buys Serendex Pharmaceuticals | Savara Pharmaceuticals, which creates drugs focused on rare respiratory diseases, announced it has a... | siliconhil... |
| 01.03.2016 | Savara raises $20M to push its inhaled antibiotic into Phase... | Austin, TX, biotech Savara Pharmaceuticals picked up $20 million in Series C cash as it moves toward... | fiercebiot... |
| 01.03.2016 | Savara Pharmaceuticals Closes $20M Series C Financing | Savara Pharmaceuticals, an Austin, TX-based specialty pharmaceutical company focusing on innovative ... | finsmes.co... |
| 01.03.2016 | Daily funding roundup - March 1, 2016 | YourMechanic raised $24M, Savara Pharmaceuticals closed $20M; Replay Technologies raised $13.5M You... | vator.tv/n... |
| 01.03.2016 | Savara Pharmaceuticals Closes on $20 Million in Venture Capi... | Savara Pharmaceuticals Tuesday announced it has closed on $20 million in Series C financing. The Au... | siliconhil... |
Show more